BILL · 2017–18 SESSION

HB 2325: Rx drug monitoring program

Concerning the prescription drug monitoring program.

Summary

Requires practitioners prescribing an opiate or benzodiazepine to review the patient's controlled substance history in the prescription monitoring program.
Exempts practitioners from the requirement to consult the prescription monitoring program if the medications are for inpatient use or to provide emergency care, or the prescription monitoring program cannot be accessed

From the House Bill Analysis 2018 (HB 2325), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee

AN ACT Relating to the prescription drug monitoring program;

No recorded floor votes. This measure never reached a floor vote.

Jan 8, 2018First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report).
Dec 26, 2017Prefiled for introduction.

Bill numbers restart every two years, so the same number is a different bill in each session.

HB 2325 (2025–26) Tourism assessment · Enacted · Chapter 229, Laws of 2026
HB 2325 (2023–24) Legislative employees · Did not pass · stalled on the House floor
HB 2325 (2019–20) Operating budget, supplement · Did not pass · stalled on the House floor
HB 2325 (2015–16) Firearms/hunting education · Did not pass · died in committee
HB 2325 (2013–14) Motorcycles/weight fee exemp · Did not pass · died in committee
HB 2325 (2011–12) Domestic violence evidence · Did not pass · died in committee
HB 2325 (2009–10) Community custody · Did not pass · died in committee
HB 2325 (2007–08) Community development fund · Did not pass · passed House, stalled in Senate